Helen Chang

Helen Chang is an accomplished marketing professional with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Head of Rare Diseases Marketing at Shionogi Inc., Helen has previously held leadership roles such as VP of Marketing at Mesoblast Limited and Executive Director of Hospital Marketing and Global Brand Lead for Inomax and Therakos at Mallinckrodt Pharmaceuticals. Additionally, Helen has experience as a Senior Director in Rare Diseases and as a Senior Business Consultant at HCH Consulting, alongside serving as a Board Member for the National Sleep Foundation. Helen Chang holds a Bachelor of Science degree in Pharmacy from Rutgers University.